XOMA Corporation XOMA Business Segments — Business Development And Deal Costs

Similar metrics at other companies

PTGXSingle Reportable — Cost Of Revenue Development Expenses Excluding Employee Expense Benefit And Allocation Share Based Compensation Expenses

$17.47M+35.4%

VERXSingle Reportable — Transaction Costs

-$5.98M-125%

ALMSSingle Reportable — Research And Development Expense

$81.54M-15.6%

CAPRSingle Reportable — Research And Development Expense

$27.38M+44.7%

IOVASingle Reportable — Research And Development Expense

$57.37M-13.1%

CLDXSingle Reportable — Research And Development Expense

$73M+38.7%

Questions, answered.

What is XOMA Corporation's business segments — business development and deal costs?

XOMA Corporation (XOMA) reported business segments — business development and deal costs of $818K in Q1 2026.

How has XOMA Corporation's business segments — business development and deal costs changed year-over-year?

XOMA Corporation's business segments — business development and deal costs decreased by 22.5% year-over-year, from $1.06M to $818K.

What is the long-term trend for XOMA Corporation's business segments — business development and deal costs?

Over 2 years (2023 to 2025), XOMA Corporation's business segments — business development and deal costs has grown at a 45.8% compound annual growth rate (CAGR), from $3.39M to $7.21M.

What does business segments — business development and deal costs mean?

Includes expenses incurred in identifying, evaluating, and executing the acquisition of new royalty interests and therapeutic assets. These costs are essential for the company's growth strategy as they represent the investment required to expand the portfolio of future economic rights.